Lilly Provides Statement in Response to Amylin Lawsuit – PR Newswire (press release)
|
Lilly Provides Statement in Response to Amylin Lawsuit
PR Newswire (press release) INDIANAPOLIS, May 16, 2011 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) has provided the following statement in response to a lawsuit and motion for temporary restraining order filed by Amylin Pharmaceuticals, Inc. against Lilly. … Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug Company news Amylin sues Eli Lilly over drug development deal |
Related posts:
UM researchers receive $23.4 million to research AIDS vaccine - Los Angeles Times
Mothers in U.S. deserve better - San Francisco Chronicle
FDA Sanctions Wider Use of Carotid Stent - U.S. News & World Report
Posted by 
